Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid, Malignant Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05781386
What this trial is testing

A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

Who this might be right for
Advanced Solid TumorCutaneous T Cell Lymphoma
Jiangsu Simcere Biologics Co., Ltd 255
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Early research (Phase 1)Study completedNCT03260322
What this trial is testing

A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 169
Early research (Phase 1)Active Not RecruitingNCT03860272
What this trial is testing

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Who this might be right for
Advanced CancerAngiosarcomaColorectal Cancer Without Liver Metastases+5 more
Agenus Inc. 499
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06873854
What this trial is testing

LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Limited 84
Testing effectiveness (Phase 2)Ended earlyNCT02712905
What this trial is testing

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 116
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Early research (Phase 1)Study completedNCT00060151
What this trial is testing

GW786034 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT05821595
What this trial is testing

JYB1907 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Jemincare 30
Early research (Phase 1)Study completedNCT01352273
What this trial is testing

MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

Who this might be right for
Advanced Solid Tumors
Array Biopharma, now a wholly owned subsidiary of Pfizer 69
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Ended earlyNCT05166577
What this trial is testing

Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC

Who this might be right for
Nasopharyngeal CarcinomaEBV-Related Gastric CarcinomaEBV-Related Leiomyosarcoma+2 more
Viracta Therapeutics, Inc. 26
Early research (Phase 1)Ended earlyNCT04467853
What this trial is testing

A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors

Who this might be right for
Solid Tumors, Adult
Shanghai East Hospital 34
Testing effectiveness (Phase 2)Ended earlyNCT03330405
What this trial is testing

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Pfizer 223
Early research (Phase 1)Study completedNCT03735628
What this trial is testing

Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)Hepatocellular Carcinoma (HCC)
Bayer 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344
What this trial is testing

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 53
Early research (Phase 1)Not Yet RecruitingNCT07593144
What this trial is testing

A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)

Who this might be right for
Advanced Solid Tumors
Foresight Therapeutics (Hefei) Co., Ltd. 156
Not applicableStudy completedNCT07167095
What this trial is testing

90-Day Mortality After Emergency Department Discharge in Advanced Cancer

Who this might be right for
Advanced CancerMortalityOncology+2 more
Ankara Etlik City Hospital 1,250
Testing effectiveness (Phase 2)Study completedNCT02869295
What this trial is testing

A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Nektar Therapeutics 28
Early research (Phase 1)Ended earlyNCT01529307
What this trial is testing

First in Human Trial of TAS266 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 6
Next Page